J&J Consumer Sales Slip Even As Recalled Brands, Seasonal Items Reach Stores
This article was originally published in The Rose Sheet
Executive Summary
J&J reports worldwide consumer sales dipped 0.6% to $3.6 billion despite retailers buying more upper respiratory and analgesic products to prepare for the cough and cold season. But in key OTC categories the firm is regaining market share it lost when its iconic brands were temporarily not available.